Lehne's Pharmacotherapeutics for
Advanced Practice Nurses and
Physician Assistants 3rd Edition Test
Bank | Jacqueline Burchum & Laura
D. Rosenthal | Complete Advanced
Pharmacology Practice Questions &
APRN/PA Exam Prep (2026)
LEHNE'S PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSES AND
PHYSICIAN ASSISTANTS 3RD EDITION
COMPREHENSIVE PRACTICE EXAMINATION - QUESTIONS
DOCUMENT OVERVIEW & STUDY FEATURES
• Complete coverage of all chapters -meticulously crafted multiple-choice
questions spanning foundational pharmacology principles through advanced
therapeutic drug classes designed for APRN and PA licensure preparation and
clinical practice mastery.
• Strategic study approach - Questions progress from basic pharmacokinetic and
pharmacodynamic concepts to complex drug interactions and clinical decision-
making scenarios; ideal for board exam prep, clinical competency development,
and evidence-based prescribing practice.
1. A 65-year-old male patient with hypertension is prescribed lisinopril. Which
of the following best describes the primary mechanism of action of ACE
inhibitors?
A) Direct vasodilation of arteriolar smooth muscle
B) Beta-adrenergic receptor antagonism
,C) Inhibition of angiotensin II formation by blocking angiotensin-converting enzyme
D) Calcium channel blockade in cardiac and vascular tissue
E) Direct renin inhibition at the juxtaglomerular apparatus
CORRECT ANSWER: C) Inhibition of angiotensin II formation by blocking
angiotensin-converting enzyme
Rationale: ACE inhibitors work by blocking the enzyme responsible for converting
angiotensin I to angiotensin II, a potent vasoconstrictor. This mechanism reduces
vasoconstriction, decreases aldosterone release, and promotes sodium and water
excretion, leading to decreased blood pressure. Options A, B, D, and E describe
mechanisms of other antihypertensive classes but not ACE inhibitors.
2. A 52-year-old woman presents with new-onset atrial fibrillation. She is
started on metoprolol for rate control. What is the primary therapeutic effect
of beta-blockers in atrial fibrillation?
A) Direct conversion of atrial fibrillation to normal sinus rhythm
B) Slowing of ventricular response rate through AV nodal conduction delay
C) Suppression of atrial ectopic foci through antiarrhythmic effects
D) Increase in atrial contractility to restore organized atrial activity
E) Prevention of thrombus formation through antiplatelet effects
CORRECT ANSWER: B) Slowing of ventricular response rate through AV nodal
conduction delay
Rationale: Beta-blockers slow conduction through the AV node, decreasing the
ventricular response rate in atrial fibrillation. While they do not convert AFib to
normal sinus rhythm (Option A is incorrect), they provide symptomatic relief by
reducing the rapid ventricular rate. Options C, D, and E describe other mechanisms
unrelated to beta-blocker actions in AFib management.
,3. A patient is prescribed amoxicillin for a streptococcal infection. Which of
the following best describes the mechanism of action of beta-lactam
antibiotics?
A) Inhibition of bacterial DNA gyrase and topoisomerase
B) Inhibition of bacterial protein synthesis at the 50S ribosomal subunit
C) Inhibition of bacterial cell wall synthesis through peptidoglycan cross-linking
disruption
D) Disruption of bacterial cell membrane integrity
E) Inhibition of bacterial folate synthesis
CORRECT ANSWER: C) Inhibition of bacterial cell wall synthesis through
peptidoglycan cross-linking disruption
Rationale: Beta-lactam antibiotics (penicillins, cephalosporins, carbapenems) inhibit
bacterial cell wall synthesis by binding to penicillin-binding proteins and preventing
cross-linking of peptidoglycan, leading to cell wall instability and bacterial death.
Options A, B, D, and E describe mechanisms of other antibiotic classes
(fluoroquinolones, tetracyclines, aminoglycosides, sulfonamides) but not beta-
lactams.
4. A 70-year-old male with chronic kidney disease is prescribed a calcium
channel blocker for hypertension. Which calcium channel blocker is most
selective for vascular tissue over cardiac tissue?
A) Verapamil
B) Diltiazem
C) Amlodipine
D) Nifedipine
E) Bepridil
CORRECT ANSWER: C) Amlodipine
, Rationale: Amlodipine and nifedipine are dihydropyridine calcium channel blockers
that have greater selectivity for vascular smooth muscle, causing vasodilation with
minimal effects on cardiac conduction and contractility. Verapamil and diltiazem
are non-dihydropyridines with significant cardiac effects. In a patient with kidney
disease, amlodipine is beneficial for its renal-protective vasodilatory effects while
minimizing cardiac depression.
5. A patient on warfarin therapy requires concurrent antibiotic therapy. The
patient is started on fluconazole for a fungal infection. Which of the following
best explains the increased bleeding risk?
A) Fluconazole increases warfarin metabolism through CYP3A4 induction
B) Fluconazole inhibits CYP2C9, decreasing warfarin metabolism and increasing INR
C) Fluconazole directly inhibits platelet function independently of warfarin
D) Fluconazole decreases vitamin K absorption in the gastrointestinal tract
E) Fluconazole competitively displaces warfarin from protein binding sites
CORRECT ANSWER: B) Fluconazole inhibits CYP2C9, decreasing warfarin
metabolism and increasing INR
Rationale: Fluconazole is a potent inhibitor of CYP2C9, the primary enzyme
responsible for warfarin metabolism. This inhibition decreases warfarin clearance,
increases its plasma concentration, and elevates the INR, increasing bleeding risk.
The patient requires INR monitoring and possible warfarin dose reduction. Option
A describes enzyme induction (opposite effect), while options C, D, and E describe
mechanisms that do not apply to this interaction.
6. A 45-year-old patient with type 2 diabetes mellitus is prescribed metformin.
Which of the following best describes the primary mechanism of action of
metformin?
A) Stimulation of pancreatic beta cells to increase insulin secretion
Advanced Practice Nurses and
Physician Assistants 3rd Edition Test
Bank | Jacqueline Burchum & Laura
D. Rosenthal | Complete Advanced
Pharmacology Practice Questions &
APRN/PA Exam Prep (2026)
LEHNE'S PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE NURSES AND
PHYSICIAN ASSISTANTS 3RD EDITION
COMPREHENSIVE PRACTICE EXAMINATION - QUESTIONS
DOCUMENT OVERVIEW & STUDY FEATURES
• Complete coverage of all chapters -meticulously crafted multiple-choice
questions spanning foundational pharmacology principles through advanced
therapeutic drug classes designed for APRN and PA licensure preparation and
clinical practice mastery.
• Strategic study approach - Questions progress from basic pharmacokinetic and
pharmacodynamic concepts to complex drug interactions and clinical decision-
making scenarios; ideal for board exam prep, clinical competency development,
and evidence-based prescribing practice.
1. A 65-year-old male patient with hypertension is prescribed lisinopril. Which
of the following best describes the primary mechanism of action of ACE
inhibitors?
A) Direct vasodilation of arteriolar smooth muscle
B) Beta-adrenergic receptor antagonism
,C) Inhibition of angiotensin II formation by blocking angiotensin-converting enzyme
D) Calcium channel blockade in cardiac and vascular tissue
E) Direct renin inhibition at the juxtaglomerular apparatus
CORRECT ANSWER: C) Inhibition of angiotensin II formation by blocking
angiotensin-converting enzyme
Rationale: ACE inhibitors work by blocking the enzyme responsible for converting
angiotensin I to angiotensin II, a potent vasoconstrictor. This mechanism reduces
vasoconstriction, decreases aldosterone release, and promotes sodium and water
excretion, leading to decreased blood pressure. Options A, B, D, and E describe
mechanisms of other antihypertensive classes but not ACE inhibitors.
2. A 52-year-old woman presents with new-onset atrial fibrillation. She is
started on metoprolol for rate control. What is the primary therapeutic effect
of beta-blockers in atrial fibrillation?
A) Direct conversion of atrial fibrillation to normal sinus rhythm
B) Slowing of ventricular response rate through AV nodal conduction delay
C) Suppression of atrial ectopic foci through antiarrhythmic effects
D) Increase in atrial contractility to restore organized atrial activity
E) Prevention of thrombus formation through antiplatelet effects
CORRECT ANSWER: B) Slowing of ventricular response rate through AV nodal
conduction delay
Rationale: Beta-blockers slow conduction through the AV node, decreasing the
ventricular response rate in atrial fibrillation. While they do not convert AFib to
normal sinus rhythm (Option A is incorrect), they provide symptomatic relief by
reducing the rapid ventricular rate. Options C, D, and E describe other mechanisms
unrelated to beta-blocker actions in AFib management.
,3. A patient is prescribed amoxicillin for a streptococcal infection. Which of
the following best describes the mechanism of action of beta-lactam
antibiotics?
A) Inhibition of bacterial DNA gyrase and topoisomerase
B) Inhibition of bacterial protein synthesis at the 50S ribosomal subunit
C) Inhibition of bacterial cell wall synthesis through peptidoglycan cross-linking
disruption
D) Disruption of bacterial cell membrane integrity
E) Inhibition of bacterial folate synthesis
CORRECT ANSWER: C) Inhibition of bacterial cell wall synthesis through
peptidoglycan cross-linking disruption
Rationale: Beta-lactam antibiotics (penicillins, cephalosporins, carbapenems) inhibit
bacterial cell wall synthesis by binding to penicillin-binding proteins and preventing
cross-linking of peptidoglycan, leading to cell wall instability and bacterial death.
Options A, B, D, and E describe mechanisms of other antibiotic classes
(fluoroquinolones, tetracyclines, aminoglycosides, sulfonamides) but not beta-
lactams.
4. A 70-year-old male with chronic kidney disease is prescribed a calcium
channel blocker for hypertension. Which calcium channel blocker is most
selective for vascular tissue over cardiac tissue?
A) Verapamil
B) Diltiazem
C) Amlodipine
D) Nifedipine
E) Bepridil
CORRECT ANSWER: C) Amlodipine
, Rationale: Amlodipine and nifedipine are dihydropyridine calcium channel blockers
that have greater selectivity for vascular smooth muscle, causing vasodilation with
minimal effects on cardiac conduction and contractility. Verapamil and diltiazem
are non-dihydropyridines with significant cardiac effects. In a patient with kidney
disease, amlodipine is beneficial for its renal-protective vasodilatory effects while
minimizing cardiac depression.
5. A patient on warfarin therapy requires concurrent antibiotic therapy. The
patient is started on fluconazole for a fungal infection. Which of the following
best explains the increased bleeding risk?
A) Fluconazole increases warfarin metabolism through CYP3A4 induction
B) Fluconazole inhibits CYP2C9, decreasing warfarin metabolism and increasing INR
C) Fluconazole directly inhibits platelet function independently of warfarin
D) Fluconazole decreases vitamin K absorption in the gastrointestinal tract
E) Fluconazole competitively displaces warfarin from protein binding sites
CORRECT ANSWER: B) Fluconazole inhibits CYP2C9, decreasing warfarin
metabolism and increasing INR
Rationale: Fluconazole is a potent inhibitor of CYP2C9, the primary enzyme
responsible for warfarin metabolism. This inhibition decreases warfarin clearance,
increases its plasma concentration, and elevates the INR, increasing bleeding risk.
The patient requires INR monitoring and possible warfarin dose reduction. Option
A describes enzyme induction (opposite effect), while options C, D, and E describe
mechanisms that do not apply to this interaction.
6. A 45-year-old patient with type 2 diabetes mellitus is prescribed metformin.
Which of the following best describes the primary mechanism of action of
metformin?
A) Stimulation of pancreatic beta cells to increase insulin secretion
